Drug firm Wyeth Ltd today reported 28.31 per cent increase in its standalone net profit to Rs 28.46 crore for the quarter ended June 30, 2014-15, mainly on account of robust sales.
The company had posted net profit of Rs 22.18 crore for the corresponding period of the previous financial year, Wyeth said in a filing to BSE.
Standalone net sales of the company also rose in the April-June quarter to Rs 191.18 crore, from Rs 164.30 crore for the same period year ago.
Wyeth Ltd is a group company of US-based pharma major Pfizer Inc and focuses in the areas of antibiotics, vaccines, corticosteroids and women's health.
